Krka DD Novo Mesto operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Krka DD Novo Mesto with three other
pharmaceutical manufacturers in Europe:
Vifor Pharma AG
sales of 1.34 billion Swiss Francs [US$1.35 billion]
of which 100%
(1.29 billion Euro [US$1.46 billion]
of which 84%
was Pharmaceuticals), and
Richter Gedeon Vegyeszeti Gyar Nyilvanosan Mukodo Reszvenytarsasag
based in Hungary
(444.36 billion Hungarian Forints [US$1.56 billion]
of which 80%
was Pharmaceutical Manufacturing and Sale).
Krka DD Novo Mesto reported sales of 1.27 billion Euro (US$1.44 billion)
December of 2017.
increase of 7.8%
versus 2016, when the company's sales were 1.17 billion Euro.
Sales of Eastern Europe saw an increase
that was more than double the company's growth rate: sales were up
16.8% in 2017, from
332.29 million Euro to 388.22 million Euro.